Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1962 to 2011 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6297.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanine-4-hydroxylase (ec 1.14.16.1) (pah) (phe-4- monooxygenase). [source:swissprot;acc:p00439]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pp3111 protein. [source:refseq;acc:nm\_022156]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 18. [source:swissprot;acc:q9p2w9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rd protein. [source:swissprot;acc:p18615]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3678.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3470.55\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
androgen-induced 1; cgi-103 protein; androgen induced protein. [source:refseq;acc:nm\_016108]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase b chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p24539]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
j domain containing protein 1. [source:swissprot;acc:q9ukb3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3678.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3470.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05993\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 complex subunit 4; likely ortholog of mouse cop9 (constitutive photomorphogenic), subunit 4 (arabidopsis); cop9 (constitutive photomorphogenic, arabidopsis, homolog) subunit 4. [source:refseq;acc:nm\_016129]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6988.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7406.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05985\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor arginine/serine-rich 11 (arginine-rich 54 kda nuclear protein) (p54). [source:swissprot;acc:q05519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5939.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6294.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain only 7; zinc-finger domain-containing protein; lomp protein; f-box only protein 20; f-box protein fbx20. [source:refseq;acc:nm\_005358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5782.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6126.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05946\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog a (hhr23a). [source:swissprot;acc:p54725]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [source:refseq;acc:nm\_001701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6176.71\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog b (hhr23b) (xp-c repair complementing complex 58 kda protein) (p58). [source:swissprot;acc:p54727]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vi. [source:swissprot;acc:q9um54]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coenzyme a thioester hydrolase 2a (ec 3.1.2.2) (peroxisomal long-chain acyl-coa thioesterase 2) (zap128). [source:swissprot;acc:p49753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6176.1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05936\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5516.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.37\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lap (leucine-rich repeats and pdz) and no pdz protein. [source:refseq;acc:nm\_018214]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5517.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coa thioesterase 2b; likely ortholog of mouse peroxisomal acyl-coa thioesterase 2b. [source:refseq;acc:nm\_152331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5829.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6175.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05934\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3559.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3360.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
m-phase inducer phosphatase 2 (ec 3.1.3.48) (dual specificity phosphatase cdc25b). [source:swissprot;acc:p30305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4383.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4642.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5045.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5344.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5429.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5749.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05902\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6174.74\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6538.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05895\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5047.2\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5344.68\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05894\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna replication licensing factor mcm5 (cdc46 homolog) (p1-cdc46). [source:swissprot;acc:p33992]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival of motor neuron protein-interacting protein 1 (smn- interacting protein 1) (component of gems 2) (gemin2). [source:swissprot;acc:o14893]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5047.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5344.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-citrate synthase (ec 2.3.3.8) (atp-citrate (pro-s-)-lyase) (citrate cleavage enzyme). [source:swissprot;acc:p53396]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6064.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6421.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrgx (morf-related gene x protein) (mortality factor 4-like 2) (msl3-2 protein). [source:swissprot;acc:q15014]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5048.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5345.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0588\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 1 subunit (mu-adaptin 1) (adaptor protein complex ap-1 mu-1 subunit) (golgi adaptor ha1/ap1 adaptin mu-1 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 1) (clathrin coat assembly protein ap47) (clathrin coat associated protein ap47) (ap-mu chain family member mu1a). [source:swissprot;acc:q9bxs5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5684.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6018.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05877\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3637.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3435.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4934.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5223.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5671.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6003.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05855\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 2 (ec 2.4.1.212) (hyaluronate synthase 2) (hyaluronic acid synthase 2) (ha synthase 2). [source:swissprot;acc:q92819]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5391.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5706.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0585\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/